Facilitating Global Innovation & Partnering

News & Events

Upcoming Event

Nicholas Hall’s North American OTC Conference 2018

The Westin Governor Morris, 2 Whippany Road, Morristown, New Jersey, 07960, United States

Date: June 20, 2018 - June 21, 2018

June 20, 2018 - June 21, 2018 @ 8:00 am - 6:00 pm - The Future of Consumer Self-Care & OTC Solutions With Rx-to-OTC Switch having been the main source of innovation in North America over recent years, this two-day event will focus on what the future holds for Consumer Self-Care & OTC. (This conference is being co-hosted by Everything Health.  Everything Health delivers innovative strategy and integrated services [...]

Upcoming Conference

Chemspec Europe 2018, the 33rd International Exhibition for Fine and Specialty Chemicals

Koelnmesse GmbH

June 20, 2018 - June 21, 2018, 9:30 am - 2:45 pm

June 20, 2018 - June 21, 2018 @ 9:30 am - 2:45 pm - Chemspec Europe 2018, the 33rd International Exhibition for Fine and Specialty Chemicals, provides buyers, traders and agents with the possibility to stay up-to-date with the latest findings in R&D, expand their network of suppliers and intensify contacts with existing and prospective business partners. Chemspec Europe offers a highly diversified yet specialized business platform that allows [...]

Latest Press Release

An Update on Digital Health

April 26, 2018

In November 2017, the FDA approved a therapeutic pill that is integrated with an ingestible sensor that can capture information about patient compliance. That product, Otsuka’s Abilify MyCite®, is indicated for schizophrenia and bipolar disorder. When the patient ingests this pill, data is sent to a patch worn on the patient’s torso. From there, the data is wirelessly transmitted to a mobile app that can be accessed by both the patient and their physician. The MyCite approval will raise awareness of this field of technology. As many as 150 firms around the world are developing digital therapeutics, according to the Economist. It is the hope that Ability MyCite, and future therapeutics like it, will be another step to increased patient compliance.